Diagnostics and pharmaceuticals containing adamts13 as a main ingredient
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- KYOTO UNIV
- Publication Date
- 2021-03-19
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to proteins in the field of medical drugs. Specifically, a full-length or partial fragment of a specific cleavage enzyme (hereinafter referred to as "ADAMTS13") related to von Willebrand Factor (von Willebrand Factor: hereinafter sometimes referred to as "vWF") involved in blood coagulation is clinically new uses of the field. Specifically, the present invention relates to the novel use of the full-length or partial fragments of ADAMTS13 in the fields of liver dysfunction, liver ischemia / reperfusion disorder and liver transplantation. Background technique
[0002] The liver is an important organ responsible for metabolism, detoxification (detoxification of alcohol or harmful substances), and biological defense (immunity). Acute hepatitis mainly refers to a disease showing acute liver dysfunction caused by hepatitis virus infection, and its symptoms include jaundice, loss of appetite, vomiting, general fatigue, and fever....